Class / Patent application number | Description | Number of patent applications / Date published |
424665000 | Alkali metal or alkaline earth metal | 56 |
20080226748 | Stabilized Chlorine Dioxide and Hypochlorous Acid in a Liquid Biocide - A liquid biocide containing stabilized chlorine dioxide and hypochlorous acid for various uses, including use as a teat dip or dairy animals. The stable, prophylactic biocide consists essentially of 0.10-20.0% by weight of a chlorite salt, 0.1-3.0% by weight of an acid, 0.10-2.0% by weight of an alkaline agent, and the balance water. Chlorite salt reacts with the acid to form germicidal chlorine dioxide and hypochlorous acid. The acid constituency and the alkaline agent constituency regulate the pH of the solution such that the biocide is stable when mixed for a period greater than two months. The present disclosure also includes a method of producing a stable, prophylactic biocide for dairy cattle, the method comprising 0.10-20.0% by weight of a chlorite salt, 0.10-3.0% by weight of an acid, 0.10-2.0% by weight of an alkaline agent, and the balance water in a container, and sealing the container. In the method, the acid and alkaline agent constituencies regulate the pH of the solution such that the formation of hydronium ions from the acid is correspondingly regulated to stabilize the solution for a period greater than two months from the date of sealing. | 09-18-2008 |
20080292729 | Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment - Pharmaceutical compositions for treating neoplastic disorders and uses thereof are provided. Said pharmaceutical compositions comprise stabilized chlorite solutions (e.g. WFIO) and a fluoropyrimidine, 5-FU, or a 5-FU prodrug (e.g. capecitabine, doxifluridine, UFT, S-1, or BOF-A2). The use of the above stabilized chlorite solution in combination with a fluoropyrimidine dramatically improves the quality of life index (QOL) of a patient undergoing cancer chemotherapy. Cancers that can be treated include cancers of the pancreas, gastrointestinal, head, neck, and breast. | 11-27-2008 |
20080311224 | Long-lasting mildew stain remover and method for making same - The active life of a fungicidal metal hydrochlorite is greatly enhanced by adding only small amounts of active fungicidal compounds selected from the group consisting of lithium hydrochlorite and iodopropynyl butyl carbamate. | 12-18-2008 |
20090017138 | TOPICAL MEDICAMENT - New topical medicaments are provided. The medicaments comprise menthol and camphor, preferably provided as part of a base gel, supplemented with potassium and a source of oxygen. The most preferred base gel is sold under the name SOMBRA, while the most preferred source of oxygen is a chlorite (e.g., sodium chlorite) and/or spirulina. The medicaments provide high metabolic activities and sustain those activities over prolonged periods of time, thus being useful for treating a large variety of ailments, including diabetic neuropathy, post hepatic neuralgia, scleroderma, psoriasis, strain, spasticity, headaches, neuropathy secondary to drugs, peripheral neuropathy, leg pain, muscle cramps, muscle aches and pains, bruise, sinusitis, sprain, arthritis, joint pain (arthralgia), and edema. | 01-15-2009 |
20090022815 | HALOGENATED COMPOSITION, METHOD FOR PREPARING SAME AND USES THEREOF - A method of stimulating tissue healing in humans or animals includes administering to a human or animal a pharmaceutically effective amount of a pharmaceutical composition which includes (i) at least one halogenated compound, and (ii) at least one N-halogenated derivative of at least one compound selected from zwitterionic compounds and/or amino acids or their derivatives. | 01-22-2009 |
20090155385 | METHODS OF REDUCING OR ELIMINATING SALMONELLA IN REPTILES AND/OR THEIR EGGS - A method for reducing or eliminating | 06-18-2009 |
20090324747 | APPARATUS AND METHOD FOR MIXING A CONCENTRATED WATER TREATMENT SOLUTION - An apparatus includes a reservoir for holding a chemical solution, a pump and a discharge nozzle. The pump has an inlet and an outlet connected to the reservoir by inlet and discharge lines. The nozzle is disposed in a lower portion of the reservoir and discharges the solution toward the bottom of the reservoir; the nozzle has an inlet port connected to the pump discharge line through the sidewall of the reservoir. The pump inlet line is connected to a sidewall of the reservoir at a location below a normal surface level of the solution, and the pump discharge line is connected to the sidewall of the reservoir above that location. The reservoir, pump, pump inlet line, pump discharge line, nozzle inlet line and nozzle form a closed loop recirculation system effective to suspend insoluble material in the chemical solution. | 12-31-2009 |
20100080857 | HALOGEN-CONTAINING SANITIZING COMPOSITION - Compositions comprising a mixture of (a) a major amount of solid halogen-containing sanitizer material and (b) a minor amount of calcium oxide modified particulate boric acid, the amount of calcium oxide modified particulate boric acid being sufficient to enable the composition to be classified as a class 1 or class 2 NFPA oxidizer are described. Also described is particulate boric acid at least a portion of the particles thereof having on their surface at least a partial coating of calcium oxide, and a method for preparing such coated particulate boric acid. | 04-01-2010 |
20100119620 | SUPPRESSING MICROBIAL GROWTH IN PULP AND PAPER - A composition for anti-microbial effect in a water system such as a pulp and paper processing line with an aqueous slurry. The composition comprises a free chlorine-generating biocide comprising a chlorine source, urea, and an alkali in a concentration sufficient to provide a pH greater than 10, and typically at least pH 11. | 05-13-2010 |
20100183744 | Systems and methods for maintaining the dominance of nannochloropsis in an algae cultivation system - Systems and methods for maintaining the dominance of | 07-22-2010 |
20100183745 | Electrochemical Device for Biocide Treatment in Agricultural Applications - The invention relates to an electrochemical device which simultaneously carries out the production of an oxidising solution at controlled composition containing hypochlorous acid and the sprinkling thereof in a continuous process, useful for biocide treatments in agricultural fields. The device can be installed on motor vehicles or mobile means in general. | 07-22-2010 |
20100183746 | BIOCIDES AND APPARATUS - A biocide is formed by mixing at least one of ammonium sulfamate and ammonium carbamate with an aqueous solution of a hypochlorite oxidant at a molar ratio of ammonium to hypochlorite of at least 1:1. The biocide is useful in treating microbial or biofilm growth, pulp and paper process water, cooling tower water, waste water, reclaimed waste water, sludge, colloidal suspensions, irrigation water or a medium having a reducing capacity. | 07-22-2010 |
20100227004 | OXIDATION METHOD AND COMPOSITIONS THEREFOR - The present invention generally relates to an improved two-part oxidizing system, as well as oxidizing compositions and methods for making and using the same, and in a particular embodiment to a two-part oxidizing system that, when mixed, yields an oxidizing composition. The two-part oxidizing system includes a metal chlorite first part, and an acid second part where the acid is sodium acid sulfate or a derivative thereof. | 09-09-2010 |
20100255121 | Hard Surface Treatment Compositions with Improved Mold or Fungi Remediation Properties - Provided are hard surface treatment compositions which provide improved mold and/or fungi remediation properties which compositions are formed from two aqueous mixtures which are admixed immediately prior to use or upon use. The hard surface treatment compositions contain an oxidizing agent, preferably a hypochlorite. In addition to a mold and/or fungi remediation effect, the composition may also be useful in the cleaning treatment and/or disinfection or sanitization treatment of hard surfaces. Methods for the remediation of mold and/or mold spores and/or fungi on surfaces are also disclosed. | 10-07-2010 |
20100272830 | Biocide Combination for use in Agricultural Applications - The invention is directed to a combination characterised by a high biocide power for use in agricultural applications, comprising a sodium or potassium hypochlorite solution and an agent allowing to generate hypochiorous acid at the moment of the application, adjusting the concentration thereof in a simple way. | 10-28-2010 |
20100303930 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY - The present invention relates to antimicrobial formulations comprising an N-halamine and a quantity of sodium chlorite sufficient to enhance the antimicrobial efficacy of the N-halamine. The present invention is further directed to formulations for disinfecting a contact lens comprising an N-halamine and a quantity of sodium chlorite sufficient to enhance the antimicrobial efficacy of the N-halamine. | 12-02-2010 |
20100310676 | BIOCIDES AND APPARATUS - A biocide is formed by mixing at least one of ammonium sulfamate and ammonium carbamate with an aqueous solution of a hypochlorite oxidant at a molar ratio of ammonium to hypochlorite of at least 1:1. The biocide is useful in treating microbial or biofilm growth, pulp and paper process water, cooling tower water, waste water, reclaimed waste water, sludge, colloidal suspensions, irrigation water or a medium having a reducing capacity. | 12-09-2010 |
20100330204 | Methods of Treating Outer Eye Disorders Using High Orp Acid Water and Compositions Thereof - The present invention relates to a method of treating an outer eye disorder selected from a cataract, neovascularization, keratitis, epithelium deficiency, or chronic opacity, by administering to the eye a composition comprising acidic electrolytic water. The present invention also relates to a stable acidic electrolyzed oxidizing water characterized by low conductivity, the presence of dissolved chlorine gas (Cl | 12-30-2010 |
20110020473 | CHLORINE DIOXIDE SOLUTION COMPOSITION - There are provided a chlorine dioxide solution composition whose solute includes dissolved chlorine dioxide and chlorite; and a solution composition encapsulating body including a glass vessel or enameled vessel and the chlorine dioxide solution composition hermetically sealed therein. | 01-27-2011 |
20110020474 | Methods of Treating Infections of the Nail or Skin Using Hypohalite - The present application discloses a method of treating or preventing an infection of a nail, claw, hoof, or skin comprising administering a pharmaceutically acceptable formulation comprising hypohalite and a formulating agent to a subject in need thereof, and compositions thereof. | 01-27-2011 |
20110052724 | CALCIUM HYPOCHLORITE COMPOSITIONS - Described are compositions containing a mixture of (a) particulate calcium hypochlorite and (b) an amount of aluminum hydroxide that is sufficient to increase the UN-burn time of the composition by a factor of at least 2.5 compared to that of the calcium hypochlorite, the composition having an available chlorine content of at least 35 weight percent. Further described are solid compositions of (a) granular calcium hypochlorite having a UN Packing Group oxidizer classification of II, and (b) an amount of aluminum hydroxide such that the composition is classified as a Packing Group III Division 5.1 oxidizer or as a non-Division 5.1 oxidizer, the composition having an available chlorine content of at least 40 weight percent. Further described are formed articles prepared from the above-described compositions. | 03-03-2011 |
20110052725 | THERAPEUTIC AGENT FOR INFECTIOUS SKIN AND MUCOSAL DISEASE - A therapeutic agent for infectious skin and mucosal diseases to be applied to an infected area for ameliorating a symptom of the infected area caused by infection with a pathogenic microorganism includes: a chlorine dioxide solution including a dissolved chlorine dioxide gas. | 03-03-2011 |
20110052726 | SOLID-LAYERED BLEACH COMPOSITIONS AND METHODS OF USE - The present invention provides a solid-layered composition having at least two parts. The first part comprises a) calcium hypochlorite, magnesium hypochlorite and mixtures thereof, b) a builder, c) a water-soluble polymer, d) an acid, and e) wherein the first part does not contain sodium hypochlorite, lithium hypochlorite, potassium hypochlorite and mixtures thereof. The second part comprises a) a functional ingredient, b) a builder or filler, and c) wherein the second part does not contain any oxidant. | 03-03-2011 |
20110091578 | METHOD OF STIMULATING TISSUE HEALING - A method of stimulating tissue healing in humans or animals includes administering to a human or animal suffering from lesions and infections linked to chronic and/or acute periodontitis a pharmaceutically effective amount of a pharmaceutical composition including (i) at least one sodium halopohalite, and (ii) at least one N-halogenated taurine, wherein halogens from the (i) at least one sodium halopohalite and from the (ii) at least one N-haloamine taurine, which may be the same or different, are selected from the group consisting of fluorine, iodine, bromine and chlorine. | 04-21-2011 |
20110250295 | AQUEOUS COMPOSITION FOR INACTIVATING SPORULATED AND/OR NON-SPORULATED COCCIDIAN PARASITES - The invention relates to an aqueous composition for inactivating sporulated and/or non-sporulated Coccidia parasites comprising 15 to 115 ppm chlorine dioxide and 0.01 to 1 wt-% of an anionic surfactant having one or more C | 10-13-2011 |
20120015051 | Chlorite Formulations and Methods of Preparation and Use Thereof - Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein. | 01-19-2012 |
20120021070 | Chlorite Formulations and Methods of Preparation and Use Thereof - Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein. | 01-26-2012 |
20120064177 | METHOD OF PREPARING AN INTRANASAL COMPOSITION AND INTRANASAL COMPOSITIONS OBTAINABLE THEREBY - The present invention relates to a method of preparing an intranasal composition including from about 0.0010-0.0040% by weight capsaicin, from about 0.50-0.90% by weight hydroxypropyl methylcellulose, from about 0.010-0.080% by weight n-alkyl dimethyl benzyl ammonium chloride (Quat), and various moisturizing and irrigation agents, wherein the method includes dissolving the above components in water to form an aqueous solution; and filtering the aqueous solution to form an intranasal composition. The present invention further relates to an intranasal drug delivery composition, which includes from about 0.0010-0.0040% by weight capsaicin, from about 0.50-0.90% by weight hydroxypropyl methylcellulose, from about 0.010-0.080% by weight n-alkyl dimethyl benzyl ammonium chloride (Quat), and various moisturizing and irrigation agents. The present invention further relates to a method to increase tolerability and reduce burning from capsaicin when applied to nasal mucosa in the form of an intranasal composition, which includes combining capsaicin with the materials as noted above. | 03-15-2012 |
20120093944 | Method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation, sterilization of electropolished and magnetoelectropolished nitinol surfaces - The method for surface inclusions detection, enhancement of endothelial and osteoblast cells adhesion and proliferation and sterilization of electropolished and magnetoelectropolished Nitinol implantable medical device surfaces uses an aqueous solution of chemical compounds containing halogenous oxyanions as hypochlorite (ClO | 04-19-2012 |
20120107418 | Method and composition for in-situ generation of chlorous acid - This invention relates to methods and compositions for producing an antimicrobial solution with a high weight percent (wt %) conversion of chlorite anion to chlorous acid and/or derivatives of chlorous acid with substantially reduced chlorite residual. Furthermore, the invention presents methods for use of the antimicrobial solution thereby substantially improving the utility and cost effectiveness of chlorous acid solutions. Furthermore, the invention further demonstrates a method for use of a novel antimicrobial solution comprising a brominated derivative of chlorous acid that has substantially reduced volatility and provides at least two different modes of oxidation. | 05-03-2012 |
20130028990 | METHOD OF USING SOLID-LAYERED BLEACH COMPOSITIONS - The present invention provides a method of using a solid-layered composition having at least two parts. The first past comprises a) calcium hypochlorite, magnesium hypochlorite and mixtures thereof, b) a builder, c) a water-soluble polymer, d) an acid, and e) wherein the first part does not contain sodium hypochlorite, lithium hypochlorite, potassium hypochlorite and mixtures thereof. The second part comprises a) a surfactant b) a builder, c) an acid, and d) wherein the second part does not contain any oxidant. | 01-31-2013 |
20130034618 | Compositions for treating the integument - Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections. | 02-07-2013 |
20130101682 | BIOCONTROL THROUGH THE USE OF CHLORINE-STABILIZER BLENDS - A composition and methods of its use, the composition comprising: a halogen source, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition is disclosed. Additionally, a method for reducing biological activity in a process stream is disclosed. The method comprises: providing a composition to a process stream, wherein said composition contains: a halogen, urea, and an additional halogen stabilizer excluding urea, optionally an alkali in a concentration sufficient to provide said composition with a pH of greater than 10; and optionally excluding a stabilized bromine compound from said composition. The invention is also directed to compositions and methods of their use as effective biocidal agents for water streams. | 04-25-2013 |
20130101683 | USE OF SULFAMIC ACID OR ITS SALTS AS STABILIZERS ESPECIALLY IN COMBINATION WITH AMMONIUM SALT AND/OR AMMINE FOR BLEACH OR OTHER HALOGEN CONTAINING BIOCIDES IN THE PAPER AREA - The invention is directed to compositions and methods of their use as effective biocidal agents for water streams. The composition comprises a halogen source, halogen stabilizers containing a sulfur bearing species and ammonium salts/urea, and an alkali. The sulfur bearing species includes sulfamic acid or its salt equivalent. By having optimized mixing ratio of halogen to stabilizer and that of ammonium salts to sulfamic acid or sulfamate, a synergistic effect occurs which both increases the efficacy of the composition as a biocide and it avoids adverse impacts on other chemicals that are present in the water stream. Best of all the composition is easy to form and easy to introduce into a water stream of concern. Its introduction can be as simple as mixing two containers of reagent prior to introduction to the water process stream. | 04-25-2013 |
20130316020 | WOUND DRESSINGS COMPRISING CHLORITE - This application described a wound dressing comprising an absorbent material, an effective amount of chlorite and an amount of a base to provide a pH of the dressing material greater than or equal to about ( | 11-28-2013 |
20140113007 | Chlorine Dioxide-Generating Product and Method for Generating Chlorine Dioxide - Provided is a chlorine dioxide-generating product comprising an inorganic porous carrier carrying a chlorite and an alkali agent. In the product, the alkali agent is carried in an amount of more than 0.7 molar equivalent and not more than 2 molar equivalents relative to the amount of the chlorite carried, and the product has a water content of 10% by weight or less. The chlorine dioxide-generating product can stably generate chlorine dioxide gas in an amount that sufficiently achieves deodorization, sterilization, virus removal, mold prevention, antisepsis, or the like of spatial environments, foods, or others but exerts no harmful effect on humans, over a long period of time. | 04-24-2014 |
20140134278 | CALCIUM HYPOCHLORITE COMPOSITION - The present invention provides a composition containing an aluminate and calcium hypochlorite, wherein the content of the aluminate is 1.0 part by weight to less than 2 parts by weight based on 100 parts by weight of the composition. | 05-15-2014 |
20140178501 | BIOCIDES AND APPARATUS - A method for controlling microbial or biofilm growth in a medium includes mixing ammonium carbamate or ammonium sulfamate with an aqueous solution of a hypochlorite oxidant to form a biocide having a pH between 9.0 and 11.5, the molar ratio of the ammonium carbamate or ammonium sulfamate to the hypochlorite being at least 1:1; and then applying the biocide to the medium. | 06-26-2014 |
20140212512 | LIQUID CHEMICAL COMPOSITION - The invention provides a liquid composition when used for maintenance of a body of water, the liquid composition comprising a solution of magnesium and potassium salts, at least one of which is a halide salt. Preferably, the liquid composition comprises Mg | 07-31-2014 |
20140287064 | Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument - Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils, plant extract oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections. | 09-25-2014 |
20140287065 | Oral Administration of Electrolyzed Water for Treatment and Prevention of PEDv in Swine, Swine Herds and Swine Confinements - Pigs infected with PEDv often die due to dehydration caused by diarrhea. Those that survive do not reach market weight as scheduled resulting in costs to the producer. The invention includes providing electrolyzed water either as treatment for infected animals or as a prophylactic against symptom severity in uninfected animals. The electrolyzed water is used as a substitute for or as a solution with regular drinking water. Duration of symptoms for infected pigs is markedly lessened; severity of symptoms is also reduced providing a much higher survival rate. Time to market is less negatively affected for surviving pigs than those untreated, and weight at scheduled time for sale is also less effected translating into positive financial results over those expected for untreated herds. | 09-25-2014 |
20140348951 | DIALYSIS PRECURSOR COMPOSITION - A dialysis acid precursor assembly including: a dry dialysis acid precursor composition including sodium chloride, a dry acid and a magnesium chloride 4.5-hydrate (MgCl2.4.5H2O), a calcium salt and at least one of a potassium salt, calcium salt and an anhydrous glucose, and a moisture-resistant container having a water vapor transmission rate less than 0.2 g/m2/d at 38° C./90% RH, wherein the dry dialysis acid precursor composition is sealed in the container. | 11-27-2014 |
20150044301 | SYSTEM FOR IMPROVING SAFETY AND EFFICACY IN THE PREPARATION OF AN INJECTION SITE - A system is disclosed for preparing a hypodermic injection site comprising a visibility enhancer for an injection site and a post injection hypodermic puncture wound site. The present invention offers a number of significant improvements which advance the efficacy of the art, by: preventing unintentional hypodermic injection of medicines through un-sanitized or under-sanitized skin surfaces, thereby protecting patients from becoming inoculated with pathogenic microorganisms while receiving such injections; significantly improving the visibility of, and, the accurate visual location and bandaging of post-injection needle puncture entry wounds, thereby further reducing the risk of infection of such wounds; and, by reducing bleeding from such wounds, which, in turn, reduces healthcare worker exposure to blood-borne pathogens and reduces the generation of potentially infectious, biohazardous medical waste. | 02-12-2015 |
20150118325 | ANTI-INFLAMMATORY SOLUTION - The present invention provides a method for preventing or treating an inflammatory response, condition or disease in a mammal comprising administering an effective amount of a dilute stabilised hypochlorite solution to said mammal in need thereof as well as a means for mixing and administering fresh, dilute stabilised hypochlorite solution to the site where it is needed. | 04-30-2015 |
20150125551 | METHOD AND APPARATUS FOR MAKING STABLE ACIDIC CHLORINATED SOLUTIONS - A method of manufacturing and an apparatus for making an aqueous chlorine solution having a pH between 3.0 and 6.5 and a stability such that after 6 weeks storage at 20 degrees Celsius the pH remains in the range 3.0 to 6.5 and the amount of chlorine lost from the solution is less than 10%, such that the method includes: | 05-07-2015 |
20150132409 | AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION - Agents and devices for affecting nerve function are described. In some variations, a combination of agents, e.g., a cardiac glycoside, an ACE inhibitor, and an NSAID are delivered to affect nerve function. The agent may be delivered locally in a site-specific manner to a targeted nerve or portion of a nerve. For example, the agent may be delivered locally to the renal nerves to impair their function and treat hypertension. One variation of a delivery device includes one or more needle housings supported by a balloon. A delivery needle is slidably disposed within a needle lumen of each needle housing. | 05-14-2015 |
20150320794 | Treatment for candidia infections - A method for treating fungal infections using a metal salt of chlorite alone or in combination with a conventional antifungal agent is disclosed. Treatment is either topical or systemic. | 11-12-2015 |
20160008387 | AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION | 01-14-2016 |
20160029639 | DUAL BIOCIDE GENERATOR - Methods and apparatus for generation of dual biocides are provided. The electrolytic generation of chlorine as a biocide is employed for further generation of additional biocides within a single system or generator, including bromine, iodine, chlorine dioxide, fluorine, or chloramines from their respective salts and/or precursors. A single on-site generating system produces a combination of biocides for applications of use providing cost, safety and efficacy improvements. Methods of using the disinfecting biocides provide a synergistic effect through simultaneous or sequential applications. | 02-04-2016 |
20160045547 | METHOD OF PREVENTING OR TREATING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION - Provided is a method for preventing or treating sinusitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water solution that is stable for at least about twenty-four hours. The ORP water solution administered in accordance with the invention can be combined with one or more suitable carriers. The ORP water solution can be administered alone or, e.g., in combination with one or more additional therapeutic agents. | 02-18-2016 |
20160100582 | WATER TREATMENT - The present invention relates to water treatment, In one example, there is provided a method of treating an aqueous system to inhibit growth of one or more micro-organisms therein and/or to reduce the number of live micro-organisms therein. The method includes adding treatment agents to an aqueous system wherein said treatment agents include:
| 04-14-2016 |
20160128322 | Disinfectant Bleach Foam Formulation - The disclosed subject matter relates to a bleach foam formulation, and to methods of use of the bleach foam formulation for the decontamination of surfaces exposed to infectious agents. disclosed subject matter provides a method for the delivery of the bleach foam formulation for the decontamination of surfaces, and specifically for the decontamination of health workers' personal protection suits, exposed to Ebola, SARS or other infectious agents. In certain embodiments, the use of the bleach foam formulation involves the delivery of the bleach foam from distances for the safe disinfection of contaminated surfaces. | 05-12-2016 |
20160136201 | METHOD OF MEDICALLY TREATING EBOLA AND OTHER ORGANISMS - A method of treating Ebola in a human patient includes covering sensitive body parts of the patent, and immersing the patient in a bath of sodium hypochlorite solution. A concentration of the sodium hypochlorite in the solution being high enough that the solution penetrates skin of the patient to react with fat tissue of the skin. | 05-19-2016 |
20160184351 | NEW COMPOSITION TO TREAT INFLAMMATION - A composition for treating inflammation in a patient by administering within an exudate of the patient, which composition includes a concentration of less than or equal to 125 mM of one or more active ingredients salt for treating one or more symptoms of such inflammation, preferably less than or equal to 100 mM, and particularly preferably less than or equal to 75 mM. | 06-30-2016 |
20160184352 | Dental Irrigant - An irrigant comprising either a hypochlorite compound or a chlorhexidine compound in combination with at least one surfactant and preferably two or more surfactants, including fluorosurfactants, ethoxylates, sulfonates, quaternary ammonium compounds, amine oxides, and combinations thereof, wherein each of the surfactants are capable of complexing with one another. | 06-30-2016 |
20170232039 | COMPOSITION AND METHOD FOR THE TREATMENT OF MUCOUS MEMBRANE INFLAMMATION | 08-17-2017 |